ScholarIQanswers from OpenAlex

Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis

PaperCitations, authors & open-access status

Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis have?

ScholarIQcitation count

Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis has 347 citations in the OpenAlex counts ScholarIQ stores.

When was Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis published?

ScholarIQyear

Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis has 2019 year in the ScholarIQ index.

What is the open-access status of Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis?

ScholarIQoa status

Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis has green oa status in the ScholarIQ index.

What is the DOI of Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis?

ScholarIQdoi

The DOI for Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis is on the source record.

What is the PMID of Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis?

ScholarIQpmid

The PMID for Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis is on the source record.

What is the OpenAlex record for Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis?

ScholarIQopenalex

The OpenAlex for Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial